NCT06393543Not yet recruiting
International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal Carcinomatosis
Source: ClinicalTrials.gov · Last updated 1 May 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To prospectively assess the incidence of peritoneal carcinomatosis for women with isolated STIC (serous tubal intraepithelial carcinoma). Moreover, to identify histopathological characteristics of STIC which are reproducible and associated to the risk of peritoneal carcinomatosis and to report the findings of additional diagnostics.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 600 (estimated)
- First submitted
- 26 Apr 2024
- Start date
- Jun 2024
- Primary completion date
- Jun 2034
- Lead sponsor
- Radboud University Medical Center
- Diseases
- Ovarian cancer
- NCT number
- NCT06393543
What you commit to
- Study type: Observational
- Planned participants: 600
- From Jun 2024 to the primary completion date, Jun 2034
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Invasive cancer at initial surgery or pathological examination (either macroscopic and/or microscopic)
Who the study is looking for
- Women
- Bilateral salpingectomy (with or without oophorectomy)
- A serous tubal intraepithelial carcinoma at histopathological review
Age in the registry: 18 years to 100 years · Sex: Female
This page is information, not medical advice. Discuss any trial with your doctor.